Cubicin and Sotalol hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported only by a few people who take Cubicin and Sotalol hydrochloride together.
The phase IV clinical study analyzes what interactions people who take Cubicin and Sotalol hydrochloride have. It is created by eHealthMe based on reports of 2 people who take the same drugs from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2 people who take Cubicin and Sotalol hydrochloride together, and have interactions are studied.
What is Cubicin?
Cubicin has active ingredients of daptomycin. It is often used in infection. eHealthMe is studying from 7,514 Cubicin users for its effectiveness, alternative drugs and more.
What is Sotalol hydrochloride?
Sotalol hydrochloride has active ingredients of sotalol hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,284 Sotalol hydrochloride users for its effectiveness, alternative drugs and more.
Number of Cubicin and Sotalol hydrochloride reports submitted per year:
Common Cubicin and Sotalol Hydrochloride drug interactions by gender *:
female:
n/a
male:
- Eosinophilic pneumonia
- Pleural effusion
- Pseudomonas infection
- Renal failure acute
- Respiratory failure
- Sinoatrial block
- Sinus node dysfunction
Common Cubicin and Sotalol Hydrochloride drug interactions by age *:
0-1:
n/a
2-9:
- Sinoatrial block
- Sinus node dysfunction
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Eosinophilic pneumonia
- Pleural effusion
- Pseudomonas infection
- Renal failure acute
- Respiratory failure
* Approximation only. Some reports may have incomplete information.
Do you take Cubicin and Sotalol hydrochloride?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Tesic D, Kostic M, Paunovic D, Jankovic SM, "Analysis of the cost–effectiveness of dronedarone versus amiodarone, propafenone, and sotalol in patients with atrial fibrillation: results for Serbia", Kardiologia Polska (Polish Heart Journal), 2016 Jan .
- Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
Related studies
Alternative drugs to, pros and cons of the 2 drugs:
- Cubicin (7,514 reports)
- Sotalol hydrochloride (3,284 reports)
Browse all drug interactions of Cubicin and Sotalol hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cubicin side effects:
- Death: 484 reports
- Fever: 334 reports
- Thrombocytopenia (decrease of platelets in blood): 325 reports
- Rashes (redness): 309 reports
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 295 reports
- Sepsis (a severe blood infection that can lead to organ failure and death): 270 reports
- Drug ineffective: 260 reports
Browse all side effects of Cubicin:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Sotalol hydrochloride side effects:
- Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 227 reports
- Hypotension (abnormally low blood pressure): 178 reports
- Breathing difficulty: 168 reports
- Weakness: 113 reports
- Bradycardia (abnormally slow heart action): 106 reports
Browse all side effects of Sotalol hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cubicin interactions:
- Cubicin and Meropenem: 531 reports
- Cubicin and Gentamicin: 448 reports
- Cubicin and Linezolid: 405 reports
- Cubicin and Furosemide: 381 reports
- Cubicin and Rifampin: 347 reports
- Cubicin and Pantoprazole: 302 reports
- Cubicin and Lasix: 264 reports
- Cubicin and Aspirin: 259 reports
- Cubicin and Lovenox: 225 reports
- Cubicin and Paracetamol: 218 reports
Browse all interactions between Cubicin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Sotalol hydrochloride interactions:
- Sotalol hydrochloride and Furosemide: 358 reports
- Sotalol hydrochloride and Aspirin: 303 reports
- Sotalol hydrochloride and Digoxin: 256 reports
- Sotalol hydrochloride and Warfarin sodium: 220 reports
- Sotalol hydrochloride and Metformin: 206 reports
- Sotalol hydrochloride and Simvastatin: 171 reports
- Sotalol hydrochloride and Coumadin: 165 reports
- Sotalol hydrochloride and Omeprazole: 151 reports
- Sotalol hydrochloride and Eliquis: 144 reports
- Sotalol hydrochloride and Lisinopril: 141 reports
Browse all interactions between Sotalol hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on daptomycin and sotalol hydrochloride (the active ingredients of Cubicin and Sotalol hydrochloride, respectively), and Cubicin and Sotalol hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cubicin and Sotalol hydrochloride.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Phenytoin and Restrictive Pulmonary Disease - 6 seconds ago
- Acyclovir and Temodar drug interaction - 9 seconds ago
- Protonix and Muscle Spasms - 24 seconds ago
- Glipizide and Disseminated Intravascular Coagulation - 24 seconds ago
- Arimidex and Listerine drug interaction - 27 seconds ago
- Lactobacillus Bifidus and Famotidine drug interaction - 30 seconds ago
- Niaspan and Darzalex drug interaction - 30 seconds ago
- Lupron and Movement Disorder - 38 seconds ago
- Sodium Fluoride and Hot Flush - 38 seconds ago
- Bystolic and Tension Headache - 42 seconds ago